Table 3 Comparison of laboratory test indicators in the two study groups
Clinical manifestations | Total (n = 100) | Non-fatal (n = 80) | Fatal (n = 20) | Wald x2 value | p value | OR (95% CI) |
|---|---|---|---|---|---|---|
WBC(< 4 × 109/L) | 80 (80%) | 63 (78.8%) | 17 (85%) | 0.391 | 0.532 | 0.654 (0.171–2.496) |
Platelet count(< 100 × 109/L) | 98 (98%) | 78 (97.5%) | 20 (100%) | 2.025 | 0.155 | 0.975 (0.941–1.010) |
ALB(< 35 g/L) | 64 (64%) | 49 (61.3%) | 15 (75%) | 1.313 | 0.252 | 0.527 (0.174–1.595) |
ALT(≥ 200U/L) | 32 (32%) | 24(30%) | 8(40%) | 0.735 | 0.391 | 0.643 (0.233–1.773) |
AST(≥ 400U/L) | 49(49%) | 31 (38.8%) | 18 (90%) | 16.817 | < 0.001 | 0.070 (0.015–0.324) |
ALP(≥ 150U/L) | 13 (13%) | 9 (11.3%) | 4 (20%) | 1.083 | 0.298 | 0.507(0.139–1.854) |
CK(≥ 1000U/L) | 36 (36%) | 22 (27.5%) | 14 (70%) | 12.543 | < 0.001 | 0.163 (0.055–0.476) |
CK-MB(≥ 100U/L) | 11(11%) | 5 (6.3%) | 6 (30%) | 9.219 | 0.002 | 0.156 (0.042–0.580) |
LDH(≥ 1000U/L) | 21 (21%) | 6 (7.5%) | 15 (75%) | 43.942 | < 0.001 | 0.027 (0.007–0.100) |
APTT(≥ 40 s) | 82(82%) | 63 (78.8%) | 19 (95%) | 2.862 | 0.091 | 0.195 (0.024–1.563) |
PT(≥ 14 s) | 18(18%) | 13 (16.3%) | 5 (40%) | 0.830 | 0.362 | 0.582 (0.180–1.882) |
SCr(≥ 110 mmol/L) | 22 (22%) | 10 (12.5%) | 12 (60%) | 21.037 | < 0.001 | 0.095 (0.031–0.290) |
BUN(≥ 7.5 mmol/L) | 43 (43%) | 27 (33.8%) | 16 (80%) | 13.964 | < 0.001 | 0.127 (0.039–0.418) |
CRP(≥ 8 mg/L) | 62 (62%) | 45 (56.3%) | 17 (85%) | 5.613 | 0.018 | 0.227 (0.062–0.836) |